Search results
Johnson & Johnson (NYSE:JNJ) is Adirondack Trust Co.’s 10th Largest Position
ETF DAILY NEWS· 6 days agoAdirondack Trust Co. cut its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks via Yahoo Finance· 4 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use...
Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a...
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 10 Best Robinhood Stocks Under $20. In this article, we are going...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 6 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
Free clinic helps educate neighbors on skin health in Southeast DC
WUSA 9 Washington, D.C.· 7 days agoOrganizers say many communities in Wards 7 and 8 are underserved when it comes to dermatology care,...
Why Diabetes, High Blood Pressure and More Conditions Can Make Heatwaves Dangerous
CNET· 3 days agoA heat wave has stifled parts of the US this week, with people across the Midwest and Northeast...
The Best LED Face Masks To Improve Wrinkles And Acne, According To Dermatologists
Women's Health via Yahoo News· 5 days agoThe best FDA-approved LED light therapy face masks, per dermatologists and editors, have benefits...
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 4 days agoARQT is focused on developing and commercializing treatments for unmet needs in immune-mediated...
Hollings Renton Sells 1,950 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock
ETF DAILY NEWS· 6 days agoAnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) Director Hollings Renton sold 1,950 shares of the business’s stock in a transaction dated Tuesday, June 18th. The stock was sold at an average ...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 6 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...